Carl Icahn Says “We See Things Boards Don’t

Carl IcahnImage source: CNBC Video Screenshot

CNBC’s David Faber and Carl Icahn, chairman, Icahn Enterprises LP (NASDAQ:IEP), discuss corporate boards, a dysfunctional system, his impact as an activist investor and why what he does is important, as well as the use of poison pills to fend off activists. He also finds himself in the unusual position of defending Bill Ackman’s recent efforts to partner with Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX) and acquire Allergan, Inc. (NYSE:AGN).

Carl Icahn: We see things boards don’t

For exclusive info on hedge funds and the latest news from value investing world at only a few dollars a month check out ValueWalk Premium right here.

Multiple people interested? Check out our new corporate plan right here (We are currently offering a major discount)

About the Author

Sheeraz Raza
Sheeraz is our COO (Chief - Operations), his primary duty is curating and editing of ValueWalk. He is main reason behind the rapid growth of the business. Sheeraz previously ran a taxation firm. He is an expert in technology, he has over 5.5 years of design, development and roll-out experience for SEO and SEM. - Email: sraza(at)

Be the first to comment on "Carl Icahn Says “We See Things Boards Don’t"

Leave a comment

Your email address will not be published.